81342 TRG@ (T cell antigen receptor, gamma) (eg, leukemia and lymphoma), gene rearrangement analysis, evaluation to detect abnormal clonal population(s)

Name of the Procedure:

T Cell Antigen Receptor, Gamma (TRG@) Gene Rearrangement Analysis
Common Name: TRG@ Gene Rearrangement Analysis
Technical Term: T Cell Receptor, Gamma Gene Rearrangement Test

Summary

T cell receptor, gamma (TRG@) gene rearrangement analysis is a laboratory test used to identify abnormal clonal populations of T cells in patients. It evaluates genetic alterations in the T cell receptor, gamma region, which can indicate the presence of certain types of leukemia or lymphoma.

Purpose

This procedure is performed to detect and diagnose abnormal clonal populations of T cells that may signify leukemia or lymphoma. The goal is to identify these malignant cells early to ensure prompt and targeted treatment.

Indications

• Unexplained lymphadenopathy (swollen lymph nodes).
• Persistent or unexplained fever.
• Night sweats and weight loss in the absence of infection.
• Elevated white blood cell count.
• Immunophenotyping indicating T cell abnormalities.
• Monitoring treatment response or disease recurrence in patients with known T cell malignancies.

Preparation

• No specific pre-procedure preparations such as fasting or medication adjustments are typically required for this test.
• A blood or tissue sample will be needed, so the patient may undergo routine blood draw or biopsy.

Procedure Description

1. Sample Collection: A blood sample is drawn or a tissue biopsy is performed by a healthcare provider.
2. DNA Extraction: DNA is isolated from the collected cells.
3. PCR Amplification: Polymerase Chain Reaction (PCR) is used to amplify the DNA segments of the TRG@ gene.
4. Gene Analysis: The amplified DNA is analyzed to detect any rearrangements in the TRG@ gene region, indicating clonal T cell populations.

Duration

The entire process from sample collection to result analysis typically takes 1-2 weeks, depending on the laboratory's protocols.

Setting

The procedure takes place in a clinical laboratory. Sample collection can occur in various settings, including hospitals, outpatient clinics, or specialized diagnostic centers.

Personnel

• Phlebotomist (for blood sample collection) or Pathologist (for tissue biopsy).
• Laboratory Technologists (for DNA extraction and amplification).
• Pathologists or Geneticists (for the analysis and interpretation of results).

Risks and Complications

• Blood draw or biopsy: minor risks include bruising, bleeding, or infection at the collection site.
• Laboratory Analysis: no direct risks to patients.

Benefits

• Accurate diagnosis of T cell malignancies such as leukemia and lymphoma.
• Early detection leads to better treatment outcomes.
• Monitoring disease progression or remission.

Recovery

• Blood draw: immediate recovery; bandage at the puncture site, mild soreness.
• Biopsy: minor discomfort, follow post-biopsy care instructions.
• No significant recovery time needed for the analysis itself.

Alternatives

• Flow cytometry: assesses cell populations based on surface markers.
• Bone marrow biopsy: provides a comprehensive view of bone marrow cells.
• These alternatives might complement rather than replace TRG@ gene rearrangement analysis, depending on the diagnosis.

Patient Experience

• During: Blood draw or biopsy may cause mild discomfort.
• After: Blood draw recovery is immediate; biopsy recovery includes minor soreness or bruising.
• Managing pain: Over-the-counter pain relief if necessary, for a biopsy.